Bascule Biosciences, Inc.
Biotechnology · NEW ROCHELLE, NY
BiotechnologySEC Form D
Bascule Biosciences, Inc. filed a Form D with the U.S. Securities and Exchange Commission on April 2, 2026, reporting $250,000 raised.
Incorporated in Delaware and based in NEW ROCHELLE, NY, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Bascule Biosciences, Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Aafia ChaudhryExecutive Officer · Director
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$10.0MRaised